- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有24家主力机构披露2025-12-31报告期持股数据，持仓量总计823.49万股，占流通A股1.04%
- 波段诊断：
-
技术面诊股
诊断结果：7.0技术面打败了83%的股票
技术面评分前10的股票
近期的平均成本为3.84元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为3.84元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"3.84","date":1787559586,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2026.08.25","stock":"-6.11","trade":"2.69","ind":"0.19"},{"date":"2026.08.24","stock":"9.95","trade":"-1.70","ind":"-0.59"},{"date":"2026.08.21","stock":"-4.12","trade":"-3.27","ind":"0.04"},{"date":"2026.08.20","stock":"1.31","trade":"2.42","ind":"0.24"},{"date":"2026.08.19","stock":"-2.54","trade":"-1.50","ind":"-2.40"},{"date":"2026.08.18","stock":"0.00","trade":"-1.04","ind":"0.19"},{"date":"2026.08.17","stock":"1.29","trade":"0.49","ind":"1.41"},{"date":"2026.08.14","stock":"-1.02","trade":"-0.81","ind":"0.01"},{"date":"2026.08.13","stock":"1.03","trade":"1.59","ind":"-0.50"},{"date":"2026.08.12","stock":"1.31","trade":"0.14","ind":"0.32"},{"date":"2026.08.11","stock":"1.32","trade":"0.34","ind":"-0.82"},{"date":"2026.08.10","stock":"0.80","trade":"0.39","ind":"0.67"},{"date":"2026.08.07","stock":"6.23","trade":"2.10","ind":"1.02"},{"date":"2026.08.06","stock":"-0.84","trade":"0.32","ind":"0.57"},{"date":"2026.08.05","stock":"-1.39","trade":"-0.59","ind":"1.47"},{"date":"2026.08.04","stock":"1.12","trade":"0.61","ind":"0.33"},{"date":"2026.08.03","stock":"0.28","trade":"0.76","ind":"-0.59"},{"date":"2026.07.31","stock":"1.42","trade":"1.71","ind":"0.72"},{"date":"2026.07.30","stock":"-2.77","trade":"-0.93","ind":"-0.62"},{"date":"2026.07.29","stock":"-0.55","trade":"0.54","ind":"0.40"},{"date":"2026.07.28","stock":"0.00","trade":"-0.02","ind":"-1.16"}]
益佰制药,上证指数,中药指数
压力支撑
该股压力位为3.83元，支撑位为3.63元。
[{"text":"\u538b\u529b\u4f4d","value":"3.83","date":1787587200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"3.63","date":1787587200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.8资金面打败了9%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：08月25日 20:31
| 机构今日流向(万元) | 1628.43 | 机构5日流向(万元) | -4411.87 |
| 机构10日流向(万元) | -10866.12 | 机构20日流向(万元) | -13686.59 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2068.46万股，其中基金数没有增加，主力净减仓30家，请投资者中长期谨慎为宜。
截止2025-12-31，共24家主力机构（基金22家，QFII2家），持仓量总计823.49万股，占流通A股1.04%
其中，基金持仓与2025-06-30相比：
增仓：6家 ，增持 10.46万股
减仓：6家 ，减持 12.32万股
新出现在主力名单中：12家 ，持有727.93万股
从主力名单中消失：42家 ，原持有2794.53万股
其中，基金持仓与2025-06-30相比：
增仓：6家 ，增持 10.46万股
减仓：6家 ，减持 12.32万股
新出现在主力名单中：12家 ，持有727.93万股
从主力名单中消失：42家 ，原持有2794.53万股
消息面诊股
诊断结果：4.1消息面打败了8%的股票
今日有利好新闻的公司
近期该股利空消息较多，投资时需谨慎。
更多>>个股资讯
- 益佰制药：8月24日获融资买入2095.40万元
2026-08-25 - 医药板块情绪升温，有药企8个交易日内录得6个涨停
2026-08-24 - 益佰制药：8月21日获融资买入1084.10万元
2026-08-22 - 益佰制药：8月20日获融资买入939.12万元
2026-08-21 - 股东追踪|戴文萍等新进益佰制药前十大流通股东
2026-08-21 - 益佰制药:公司将于8月27日召开2026年半年度业
2026-08-20 - 益佰制药（截止2026年6月30日）股东人数为50
2026-08-20 - 财报速递：益佰制药2026年半年度净亏损8033.
2026-08-23 - 益佰制药半年度营业收入6.89亿元，同比下降30.
2026-08-20 - 益佰制药：2026年上半年净利润亏损8033.78
2026-08-20
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-08-01 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-07-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-23 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-23 |
| 重大利空 | 业绩预告 | 预计续亏 | 2026-01-22 |
| 重大利空 | 业绩预告 | 预计续亏 | 2026-01-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-28 |
| 一般消息 | 高管变动 | 个人原因 | 2025-11-26 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-05 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 4条 | 3条 | 1条 |
行业面诊股
诊断结果：6.4行业面打败了74%的股票
中药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.08.25","price":"0.19","value":"2.69"},{"date":"2026.08.24","price":"-0.59","value":"-1.70"},{"date":"2026.08.21","price":"0.04","value":"-3.27"},{"date":"2026.08.20","price":"0.24","value":"2.42"},{"date":"2026.08.19","price":"-2.40","value":"-1.50"},{"date":"2026.08.18","price":"0.19","value":"-1.04"},{"date":"2026.08.17","price":"1.41","value":"0.49"},{"date":"2026.08.14","price":"0.01","value":"-0.81"},{"date":"2026.08.13","price":"-0.50","value":"1.59"},{"date":"2026.08.12","price":"0.32","value":"0.14"},{"date":"2026.08.11","price":"-0.82","value":"0.34"},{"date":"2026.08.10","price":"0.67","value":"0.39"},{"date":"2026.08.07","price":"1.02","value":"2.10"},{"date":"2026.08.06","price":"0.57","value":"0.32"},{"date":"2026.08.05","price":"1.47","value":"-0.59"},{"date":"2026.08.04","price":"0.33","value":"0.61"},{"date":"2026.08.03","price":"-0.59","value":"0.76"},{"date":"2026.07.31","price":"0.72","value":"1.71"},{"date":"2026.07.30","price":"-0.62","value":"-0.93"},{"date":"2026.07.29","price":"0.40","value":"0.54"},{"date":"2026.07.28","price":"-1.16","value":"-0.02"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 汉森制药 | 76.14% | 61.18% | 5.7分 |
| 2 | 华森制药 | 25.92% | -0.51% | 5.7分 |
| 3 | 维康药业 | 22.97% | -5.94% | 5.6分 |
| 4 | 粤万年青 | 20.61% | -8.97% | 4.6分 |
| 5 | 三力制药 | 20.14% | -2.91% | 4.5分 |
| 6 | 陇神戎发 | 17.68% | -13.33% | 4.9分 |
| 8 | 新天药业 | 16.29% | 4.15% | 5.6分 |
| 10 | 华神科技 | 12.67% | 0.72% | 6.0分 |
| 12 | 益盛药业 | 10.75% | 3.49% | 6.0分 |
| 14 | 新光药业 | 10.58% | 4.81% | 5.9分 |
| 16 | 盘龙药业 | 8.54% | -1.32% | 5.7分 |
| 18 | ST葫芦娃 | 8.11% | 1.52% | 5.0分 |
| 20 | 亚宝药业 | 7.86% | -1.27% | 6.3分 |
| 22 | ST嘉应 | 7.26% | 0.89% | 5.2分 |
| 24 | - | 6.03% | -3.34% | 分 |
| 26 | 信邦制药 | 5.44% | 0.32% | 5.5分 |
| 28 | 寿仙谷 | 4.70% | -0.66% | 4.8分 |
| 30 | - | 4.48% | -4.11% | 分 |
| 32 | 康美药业 | 2.24% | -1.44% | 4.3分 |
| 34 | 红日药业 | 1.77% | -1.99% | 5.3分 |
| 36 | ST金花 | 1.26% | 0.63% | 5.0分 |
| 38 | ST百灵 | 0.88% | 0.44% | 5.6分 |
| 40 | 佐力药业 | 0.79% | -2.90% | 5.7分 |
| 42 | 马应龙 | -0.39% | 1.26% | 5.5分 |
| 44 | 步长制药 | -0.84% | -3.04% | 5.0分 |
| 46 | 葵花药业 | -2.21% | -0.38% | 5.7分 |
| 48 | 上海凯宝 | -2.61% | -5.08% | 4.7分 |
| 50 | 以岭药业 | -3.07% | -4.23% | 5.8分 |
| 52 | 天目药业 | -3.25% | -6.39% | 5.0分 |
| 54 | 众生药业 | -3.78% | -10.53% | 5.7分 |
| 56 | ST万邦 | -4.29% | -4.10% | 5.8分 |
| 58 | 广誉远 | -4.76% | -0.73% | 5.5分 |
| 60 | 太极集团 | -5.48% | -10.61% | 4.9分 |
| 62 | 东阿阿胶 | -5.98% | -5.05% | 5.2分 |
| 64 | 天士力 | -6.23% | -4.16% | 5.3分 |
| 66 | 华润江中 | -8.46% | -2.32% | 5.9分 |
| 68 | 珍宝岛 | -18.46% | -10.10% | 4.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 62/108 ， 29/108。
[{"date":"2026-03-31","value":"-1.36","vol":"2.21"},{"date":"2025-12-31","value":"-14.09","vol":"-2.33"},{"date":"2025-09-30","value":"-3.54","vol":"4.80"},{"date":"2025-06-30","value":"-0.80","vol":"4.03"},{"date":"2025-03-31","value":"-0.38","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-1.36 | -14.09 | -3.54 | -0.80 | -0.38 |
| 行业(%) | 2.21 | -2.33 | 4.80 | 4.03 | 2.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"57.92","vol":"55.05"},{"date":"2025-12-31","value":"59.66","vol":"52.85"},{"date":"2025-09-30","value":"60.32","vol":"53.29"},{"date":"2025-06-30","value":"60.65","vol":"53.82"},{"date":"2025-03-31","value":"60.17","vol":"54.48"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
57.92 | 59.66 | 60.32 | 60.65 | 60.17 |
| 行业(%) | 55.05 | 52.85 | 53.29 | 53.82 | 54.48 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 60/108 ， 61/108。
[{"date":"2026-03-31","value":"-28.44","vol":"-5.58"},{"date":"2025-12-31","value":"-14.31","vol":"-6.76"},{"date":"2025-09-30","value":"-15.59","vol":"-7.84"},{"date":"2025-06-30","value":"-14.99","vol":"-7.78"},{"date":"2025-03-31","value":"-12.43","vol":"-7.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-28.44 | -14.31 | -15.59 | -14.99 | -12.43 |
| 行业(%) | -5.58 | -6.76 | -7.84 | -7.78 | -7.40 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-214.57","vol":"1.06"},{"date":"2025-12-31","value":"-3.89","vol":"-80.25"},{"date":"2025-09-30","value":"48.83","vol":"-2.78"},{"date":"2025-06-30","value":"81.31","vol":"2.25"},{"date":"2025-03-31","value":"86.29","vol":"-37.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-214.57 | -3.89 | 48.83 | 81.31 | 86.29 |
| 行业(%) | 1.06 | -80.25 | -2.78 | 2.25 | -37.69 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 38/108 ， 54/108。
[{"date":"2026-03-31","value":"0.10","vol":"0.12"},{"date":"2025-12-31","value":"0.49","vol":"0.47"},{"date":"2025-09-30","value":"0.36","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.12","vol":"0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.49 | 0.36 | 0.24 | 0.12 |
| 行业(次) | 0.12 | 0.47 | 0.35 | 0.24 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.28","vol":"0.59"},{"date":"2025-12-31","value":"1.30","vol":"2.34"},{"date":"2025-09-30","value":"1.00","vol":"1.72"},{"date":"2025-06-30","value":"0.66","vol":"1.17"},{"date":"2025-03-31","value":"0.33","vol":"0.59"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.28 | 1.30 | 1.00 | 0.66 | 0.33 |
| 行业(次) | 0.59 | 2.34 | 1.72 | 1.17 | 0.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"12.59","vol":"5.83"},{"date":"2025-12-31","value":"12.71","vol":"30.77"},{"date":"2025-09-30","value":"7.33","vol":"10.53"},{"date":"2025-06-30","value":"33.16","vol":"22.82"},{"date":"2025-03-31","value":"1.50","vol":"2.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 12.59 | 12.71 | 7.33 | 33.16 | 1.50 |
| 行业 | 5.83 | 30.77 | 10.53 | 22.82 | 2.06 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.18","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.14","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.18 | - | 0.14 | - |
| 行业 | 0.00 | 1.00 | 0.00 | 1.03 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/108 ， 1/108。
[{"date":"2026-03-31","value":"1.70","vol":"2.97"},{"date":"2025-12-31","value":"1.59","vol":"2.94"},{"date":"2025-09-30","value":"1.88","vol":"3.09"},{"date":"2025-06-30","value":"1.80","vol":"2.94"},{"date":"2025-03-31","value":"1.84","vol":"3.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.70 | 1.59 | 1.88 | 1.80 | 1.84 |
| 行业 | 2.97 | 2.94 | 3.09 | 2.94 | 3.03 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.01","vol":"2.23"},{"date":"2025-12-31","value":"0.94","vol":"2.15"},{"date":"2025-09-30","value":"1.16","vol":"2.24"},{"date":"2025-06-30","value":"1.14","vol":"2.15"},{"date":"2025-03-31","value":"1.11","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.01 | 0.94 | 1.16 | 1.14 | 1.11 |
| 行业 | 2.23 | 2.15 | 2.24 | 2.15 | 2.24 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/108 ， 25/108。
[{"date":"2026-03-31","value":"34.03","vol":"31.94"},{"date":"2025-12-31","value":"34.03","vol":"32.43"},{"date":"2025-09-30","value":"34.46","vol":"31.59"},{"date":"2025-06-30","value":"36.24","vol":"32.45"},{"date":"2025-03-31","value":"35.05","vol":"31.91"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
34.03 | 34.03 | 34.46 | 36.24 | 35.05 |
| 行业(%) | 31.94 | 32.43 | 31.59 | 32.45 | 31.91 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.54","vol":"0.66"},{"date":"2025-12-31","value":"0.54","vol":"0.67"},{"date":"2025-09-30","value":"0.55","vol":"0.76"},{"date":"2025-06-30","value":"0.59","vol":"0.75"},{"date":"2025-03-31","value":"0.56","vol":"0.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.54 | 0.54 | 0.55 | 0.59 | 0.56 |
| 行业(%) | 0.66 | 0.67 | 0.76 | 0.75 | 0.74 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-4.26","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.03","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.17","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-3.30","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]